Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Trial to Demonstrate the Efficacy of Cangrelor (PCI)
This study has been terminated.
( Insufficient evidence of the clinical effectiveness of cangrelor )
Study NCT00305162   Information provided by The Medicines Company
First Received: March 17, 2006   Last Updated: January 13, 2012   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been terminated.
  Study Completion Date: June 2010
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
No publications provided by The Medicines Company

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV Jr, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RC, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL. Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med. 2009 Dec 10;361(24):2318-29.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services